(Q40451717)

English

Artificial zinc finger fusions targeting Sp1-binding sites and the trans-activator-responsive element potently repress transcription and replication of HIV-1.

scientific article published on 2 March 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Artificial zinc finger fusions targeting Sp1-binding sites and the trans-activator-responsive element potently repress transcription and replication of HIV-1. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Carine Van Lint

10

object named as

Carine Van Lint

0 references

author name string

Yeon-Soo Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jung-Min Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Deug-Lim Jung

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jae-Eun Kang

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sukyung Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jin Soo Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Wongi Seol

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Hyun-Chul Shin

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Heung Sun Kwon

9

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Nouria Hernandez

11

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Man-Wook Hur

12

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

2 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

280

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

21545-21552

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Multifaceted activities of the HIV-1 transactivator of transcription, Tat.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

Repression of the HIV-1 5' LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

HIV-1: fifteen proteins and an RNA

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

Human zinc fingers as building blocks in the construction of artificial transcription factors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

Design of novel sequence-specific DNA-binding proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

Custom DNA-binding proteins and artificial transcription factors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

Attenuation of HIV-1 replication in primary human cells with a designed zinc finger transcription factor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

HIV-1 tat transcriptional activity is regulated by acetylation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

Examination of TAR-independent Trans activation by human immunodeficiency virus type 1 Tat in human glial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

Tat and trans-activation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

Role of the histone deacetylase complex in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

Modulation of HIV-1 replication by RNA interference

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414136200

21 January 2018

Identifiers

10.1074/JBC.M414136200

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40451717&oldid=1493978709"